In case you missed SenzaGen’s Scientific Session at this year’s SOT, here is a new opportunity!
Together with guest speakers from ExxonMobil Biomedical Sciences Inc. and Research Institute for Fragrance Materials, Inc. (RIFM), SenzaGen’s Andy Forreryd, PhD will present the latest GARD® data on quantitative risk assessment and regulatory testing of skin sensitizers, and the potential to further broaden the GARD® applicability.
· Quantitative potency assessments
· UVCBs and formulated lubricant products
· Agrochemical formulations
· Acrylate monomers
· Regulatory acceptance according to MDR
· New application: Photosensitization
Assessing the Utility of the GARD®skin Assay to Detect Dermal Sensitization Potential in UVCBs and Formulated Lubricant Products
Allison Greminger, PhD, DABT
Toxicology Associate @ExxonMobil Biomedical Sciences Inc.
Dr. Greminger is a board-certified toxicologist who provides scientific and regulatory support to several ExxonMobil Product Solutions businesses. In her current position, she reviews and evaluates toxicological data to support regulatory compliance for current products, as well as guide new product development. Dr. Greminger has a specific interest in local hazards relevant for formulated products and has conducted various research on implementing non-animal testing strategies to inform hazard potential.
An introduction to photosensitization and why there is a need for development of predictive assays capable of discriminating between photosensitization and photoirritancy
Principal toxicologist @Research Institute for Fragrance Materials, Inc. (RIFM)
Gretchen Ritacco leads the Photosafety program at the Research Institute for Fragrance Materials (RIFM). Her duties include evaluating fragrance materials in support of RIFM’s Fragrance Ingredient Safety Assessments and managing RIFM’s photoallergy research. In addition, she is engaged in collaborations with industry leaders to investigate new approaches to evaluate the photoallergenic potential of fragrance materials. Before RIFM, Gretchen worked in the Allergy and Asthma Discovery Research group at Schering Plough Research Institute. She evaluated lead development candidates for treating pulmonary disorders, refined measurement of allergic airway disease, and investigated markers of airway inflammation. Gretchen is a member of the Society of Toxicology (SOT) and both the European and American Societies of Photobiology (ESP & ASP, respectively).
New GARD data on skin sensitization testing: “difficult-to-test” substances and quantitative potency assessment and regulatory testing of Medical Devices
Andy Forreryd, PhD
Scientific Liaison @ SenzaGen
Dr Forreryd has many years of experience working with in vitro assay development, genomics and machine learning. He is also co-developer of the GARD platform for the assessment of chemical sensitizers and is the inventor of two patents related to the technology.